| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0002 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.19 | 0.0003 |